Ειδήσεις: IOT | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

25/03 11:25 cbsnews.com

FDA says billionaire's claims about cancer drug Anktiva are misleading

FDA Anktiva Patrick Soon‑Shiong bladder cancer misleading claims biotech

25/03 10:30 statnews.com

STAT+: How an outsider crept into Eli Lilly’s top ranks — and plans to drive its business forward

outsider Eli Lilly Loxo Oncology business strategy biotech leadership

25/03 09:51 investing.com

Aptamer Group reports 27% revenue growth on pharma contracts

Aptamer Group revenue growth pharma contracts biotechnology drug discovery 27%

25/03 09:39 defenseworld.net

Resverlogix (TSE:RVX) Shares Cross Below 50-Day Moving Average – What’s Next?

Resverlogix TSE:RVX 50‑day moving average epigenetic drug apabetalone biotech

25/03 09:24 defenseworld.net

Generate Biomedicines (NASDAQ:GENB) Coverage Initiated by Analysts at The Goldman Sachs Group

Generate Biomedicines Goldman Sachs Guggenheim Cantor Fitzgerald buy rating price target

25/03 08:58 defenseworld.net

Patriot National Bancorp (NASDAQ:PNBK) Stock Crosses Above 200 Day Moving Average – Here’s Why

Patriot National Bancorp PNBK 200‑day moving average sell rating stock performance market volume

25/03 08:48 defenseworld.net

Tevogen Bio (TVGN) to Release Quarterly Earnings on Wednesday

Tevogen Bio earnings release TVGN NASDAQ analyst downgrade biotech

25/03 08:09 defenseworld.net

Reply (OTCMKTS:RPYTF) Trading Down 16.9% – Should You Sell?

Reply S.p.A.OTCMKTS:RPYTF stock decline digital services IoT trading volume

25/03 08:00 defenseworld.net

Palvella Therapeutics (NASDAQ:PVLA) Given New $270.00 Price Target at HC Wainwright

Palvella Therapeutics price target brokerage buy rating HC Wainwright BTIG

25/03 08:00 defenseworld.net

Palvella Therapeutics (NASDAQ:PVLA) Given New $270.00 Price Target at HC Wainwright

Palvella Therapeutics price target brokerage buy rating HC Wainwright BTIG

Loading...